**COVID-19 (novel coronavirus) Information**

**Monkeypox Information**


The Antimicrobial Stewardship Program (ASP) at Michigan Medicine is a collaborative effort between the Division of Infectious Diseases, the Division of Pediatric Infectious Diseases, the Department of Pharmacy Services, Infection Prevention, and Clinical Microbiology. The ASP was established to promote safe, appropriate and cost-effective antimicrobial therapy to optimize patient outcomes and to minimize the selection of pathogenic microorganisms and the emergence of resistance. Tejal N. Gandhi, MD, Clinical Associate Professor, Division of Infectious Diseases, directs the ASP in conjunction with Samuel Aitken PharmD, Ji Baang MD, Nicholas Dillman PharmD, Gregory Eschenauer PharmD, Kristin Klein PharmD, Elizabeth Lloyd MD, Jerod Nagel PharmD, Lindsay Petty MD, Jason Pogue PharmD, Jennifer Sweeney MPH, Alison Tribble MD, and Shiwei Zhou MD.

This website is one of our forums for introducing both new strategies and modifications of existing strategies designed to encourage judicious use of antimicrobials. It is our goal provide clinically relevant information on the use of antimicrobials, both new and old, as well as information on other activities of the ASP.

**The guidelines contained on this webpage utilize local antimicrobial susceptibilities at Michigan Medicine to determine empiric antimicrobial selection. Empiric selection at other institutions may differ due to variations in local susceptibilities**